Drug profile · INN
praziquantel
DISTOCIDE (KOREA)
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
praziquantel (DISTOCIDE (KOREA)) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN praziquantel
Brand DISTOCIDE (KOREA)
Route ORAL
Formulation TABLET
Originator Lacuna Pharma Pty Ltd
Frequently asked questions
What is praziquantel?
praziquantel (DISTOCIDE (KOREA)) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for praziquantel?
DISTOCIDE (KOREA) is a marketed brand name for praziquantel. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of praziquantel?
praziquantel has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.